Cargando…
Effectiveness of Messenger RNA Vaccines against SARS-CoV-2 Infection in Hemodialysis Patients: A Case–Control Study
Patients with end-stage kidney disease (ESKD) are at increased risk for SARS-CoV-2 infection and its complications compared with the general population. Several studies evaluated the effectiveness of COVID-19 vaccines in the dialysis population but showed mixed results. The aim of this study was to...
Autores principales: | Alkadi, Mohamad M., Hamad, Abdullah, Ghazouani, Hafedh, Elshirbeny, Mostafa, Ali, Mohamed Y., Ghonimi, Tarek, Ibrahim, Rania, Abuhelaiqa, Essa, Abou-Samra, Abdul Badi, Al-Malki, Hassan, Butt, Adeel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863461/ https://www.ncbi.nlm.nih.gov/pubmed/36679894 http://dx.doi.org/10.3390/vaccines11010049 |
Ejemplares similares
-
From past to present: Exploring COVID-19 in Qatar’s hemodialysis population across Omicron dominant and pre-Omicron periods
por: Hamad, Abdullah, et al.
Publicado: (2023) -
Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar
por: Al-Ali, Fadwa, et al.
Publicado: (2021) -
Time-Series Forecasting of Hemodialysis Population in the State of Qatar by 2030
por: Hamad, Abdullah, et al.
Publicado: (2023) -
National response to the COVID-19 Omicron variant crisis in the ambulatory hemodialysis service in the State of Qatar
por: Hamad, Abdullah I., et al.
Publicado: (2022) -
Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience
por: Alkadi, Mohamad M., et al.
Publicado: (2021)